tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Income Statement

Compare
197 Followers

Pharming Group Income Statement

Last quarter (Q4 2025), Pharming Group's total revenue was €90.58M, a decrease of -2.26% from the same quarter last year. In Q4, Pharming Group's net income was €4.51M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 321.12M€ 297.20M€ 245.32M€ 205.62M€ 198.87M
Gross Profit
€ 282.27M€ 261.80M€ 220.10M€ 188.06M€ 177.73M
Operating Expenses
€ 265.78M€ 270.42M€ 225.49M€ 169.83M€ 164.17M
Depreciation and Amortization
€ 9.58M€ 16.07M€ 15.93M€ 13.19M€ 19.61M
EBITDA
€ 26.06M€ 16.32M€ 9.88M€ 33.53M€ 48.78M
Operating Income
€ 16.49M€ -8.62M€ -5.39M€ 18.23M€ 13.56M
Other Income/Expenses
€ -5.52M€ 129.00K€ -6.63M€ -3.25M€ 9.52M
Pretax Income
€ 10.97M€ -8.49M€ -12.01M€ 14.99M€ 23.08M
Net Income
€ 2.43M€ -11.84M€ -10.55M€ 13.67M€ 16.00M
Per Share Metrics
Basic EPS
€ 0.03€ -0.17€ -0.14€ 0.17€ 0.20
Diluted EPS
€ 0.03€ -0.17€ -0.14€ 0.16€ 0.18
Weighted Average Shares Outstanding
71.32M 68.92M 65.70M 82.54M 87.64M
Weighted Average Shares Outstanding (Diluted)
71.32M 68.92M 65.70M 84.28M 87.64M
Currency in EUR

Pharming Group Earnings and Revenue History